Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Negative electrode material for non-aqueous electrolyte secondary battery, method for manufacturing negative electrode material for non-aqueous electrolyte secondary battery, non-aqueous elect
Method for eliciting an immune response to human telomerase reverse transcriptase
High-frequency-link power-conversion system having direct double-frequency ripple current control and method of use
System and method for detecting an earth ground fault of an external power supply connected to a vehicle
Methods and apparatus for dynamic identification (ID) assignment in wireless networks
Time sharing type autostereoscopic display apparatus and method for driving the same
Acrylic pressure-sensitive adhesive composition, acrylic pressure-sensitive adhesive layer, and acrylic pressure-sensitive adhesive tape
  Randomly Featured Patents
Ionizer with drop-off prevention device for electrode
Wheel insert attachment system
Method and apparatus for frequency analysis of telephone signals
Methods and systems for treating ischemia
Tier drop grid system
Grooved cleaning blade with end seals
Twin impeller drive for jet pump
Sheet-like object feed unit in sheet-fed rotary printing press
Activity slide toy
Dual-in-line universal serial bus connector